{"content":[{"text":"LEGISLATURE OF THE STATE OF IDAHO \n Sixty-seventh Legislature Second Regular Session – 2021","bbox":{"left":0.117647,"top":0.091498,"width":0.71902,"height":0.03420300000000001}},{"text":"IN THE HOUSE OF REPRESENTATIVES","bbox":{"left":0.325686,"top":0.143771,"width":0.34835699999999997,"height":0.01677899999999999}},{"text":"HOUSE BILL NO.","bbox":{"left":0.423922,"top":0.178619,"width":0.1517639999999999,"height":0.01677899999999999}},{"text":"BY","bbox":{"left":0.486275,"top":0.213468,"width":0.027297000000000016,"height":0.01677899999999999}},{"text":"AN ACT \n RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2701, IDAHO \n CODE, TO ADDRESS THE DESCHEDULING OF FDA APPROVED CANNABIDIOL, \n AMENDING SECTION 37-2705, AMENDING SECTION 37-2707, AMENDING \n SECTION 37-2711, AMENDING SECTION 37-2713 IDAHO CODE, TO REVISE THE \n LISTS OF SCHEDULE I, II, IV AND V CONTROLLED SUBSTANCES.","bbox":{"left":0.117647,"top":0.248316,"width":0.7647059999999999,"height":0.10389999999999996}},{"text":"Be It Enacted by the Legislature of the State of Idaho:","bbox":{"left":0.117647,"top":0.370286,"width":0.423486,"height":0.01677899999999999}},{"text":"SECTION 1: \n read as follows:","bbox":{"left":0.117647,"top":0.405134,"width":0.161526,"height":0.03420400000000001}},{"text":"That Section 37-2701, Idaho Code, be, and the same is hereby amended to","bbox":{"left":0.294118,"top":0.405134,"width":0.5882350000000001,"height":0.01677899999999999}},{"text":"37-2701.DEFINITIONS. As used in this chapter: \n (a) \"Administer\" means the direct application of a controlled substance whether by \n injection, inhalation, ingestion, or any other means, to the body of a patient or research subject by: \n (1) A practitioner or, in his presence, by his authorized agent; or \n (2) The patient or research subject at the direction and in the presence of the practitioner. \n (b) \"Agent\" means an authorized person who acts on behalf of or at the direction of a \n manufacturer, distributor or dispenser. It does not include a common or contract carrier, public \n warehouseman or employee of the carrier or warehouseman. \n (c) \"Board\" means the state board of pharmacy created in chapter 17, title 54, Idaho \n Code, or its successor agency. \n (d) \"Bureau\" means the drug enforcement administration, United States department of \n justice, or its successor agency. \n (e) \"Controlled substance\" means a drug, substance or immediate precursor in schedules I \n through VI of article II of this chapter. \n (f) \"Counterfeit substance\" means a controlled substance which, or the container or labeling \n of which, without authorization, bears the trademark, trade name, or other identifying mark, \n imprint, number or device, or any likeness thereof, of a manufacturer, distributor or dispenser other \n than the person who in fact manufactured, distributed or dispensed the substance. \n (g) \"Deliver\" or \"delivery\" means the actual, constructive, or attempted transfer from one \n (1) person to another of a controlled substance, whether or not there is an agency relationship. \n (h) \"Director\" means the director of the Idaho state police. \n (i) \"Dispense\" means to deliver a controlled substance to an ultimate user or research subject \n by or pursuant to the lawful order of a practitioner, including the packaging, labeling, or \n compounding necessary to prepare the substance for that delivery. \n (j) \"Dispenser\" means a practitioner who dispenses.","bbox":{"left":0.117647,"top":0.457407,"width":0.764961,"height":0.43571899999999997}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}